COVID-19 Pandemic: a World in Turmoil
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Trump to Shut Off Tiktok, Wechat to New U.S. Users on Sunday
For news and information consider- If you would like to share news or news organization events, and school Mr. Lee’s Commen- ation, please send to If information with our readers, please news to us includinig your name and [email protected] tary and Dairy send the unique stories, business phone number in case more informa- tion is needed. or contact John Robbins 832-280-5815 Jun Gai 281-498-4310 Publisher: Wea H. Lee President: Catherine Lee Editor: John Robbins, Jun Gai Address: 11122 Bellaire Blvd., Houston, TX 77072 E-mail: [email protected] Southern Daily News is published by Southern News Group Daily Inside C2 Saturday September 19 2020 | www.today-america.com | Southern News Group Trump to shut off TikTok, WeChat to new U.S. users on Sunday WASHINGTON (Reuters) - The Trump administration WeChat developer Tencent Holdings’ called the order will ban WeChat and video-sharing app TikTok from U.S. “We have some great options and maybe we can keep a lot of “unfortunate” but said it “will continue to discuss with app stores starting Sunday night, a move that will block people happy,” Trump told reporters. “We have to have the total the government and other stakeholders in the U.S. ways Americans from downloading the Chinese-owned plat- security from China.” to achieve a long-term solution.” forms over concerns they pose a national security threat. Commerce Secretary Wilbur Ross told Fox Business Network that The Commerce Department order bars Apple Inc’s app The bans, announced on Friday, affect only new “the basic TikTok will stay intact until Nov. -
Emerging Leaders in Biosecurity Initiative
Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles. -
The Fourth Paradigm
ABOUT THE FOURTH PARADIGM This book presents the first broad look at the rapidly emerging field of data- THE FOUR intensive science, with the goal of influencing the worldwide scientific and com- puting research communities and inspiring the next generation of scientists. Increasingly, scientific breakthroughs will be powered by advanced computing capabilities that help researchers manipulate and explore massive datasets. The speed at which any given scientific discipline advances will depend on how well its researchers collaborate with one another, and with technologists, in areas of eScience such as databases, workflow management, visualization, and cloud- computing technologies. This collection of essays expands on the vision of pio- T neering computer scientist Jim Gray for a new, fourth paradigm of discovery based H PARADIGM on data-intensive science and offers insights into how it can be fully realized. “The impact of Jim Gray’s thinking is continuing to get people to think in a new way about how data and software are redefining what it means to do science.” —Bill GaTES “I often tell people working in eScience that they aren’t in this field because they are visionaries or super-intelligent—it’s because they care about science The and they are alive now. It is about technology changing the world, and science taking advantage of it, to do more and do better.” —RhyS FRANCIS, AUSTRALIAN eRESEARCH INFRASTRUCTURE COUNCIL F OURTH “One of the greatest challenges for 21st-century science is how we respond to this new era of data-intensive -
Framework on Accumulating Evidence Across Outbreaks
Framework on accumulating evidence across outbreaks NATALIE DEAN DEPARTMENT OF BIOSTATISTICS UNIVERSITY OF FLORIDA WHO R&D BLUEPRINT CONSULTATION ON CLINICAL TRIAL DESIGNS NOVEMBER 29, 2018, GENEVA Kennedy et al. (2016) DOI: 10.1177/1740774515621037 2 Figure: Weekly incidence of Ebola in Guinea 2014–15, and key dates in the ring vaccination trial 3 doi:10.1126/science.aav3996 4 National Academies of Sciences, Engineering, and Medicine (2017) https://doi.org/10.17226/24739 5 http://www.who.int/emergencies/mers-cov/epi-18-september-2018.png 6 Motivation Outbreaks are of unpredictable size and duration All outbreaks represent an opportunity to advance research and development efforts There is considerable risk that trials will be underpowered and results from trials terminated due to low accrual will be inconclusive Prejudgment of promising but inconclusive results can: . Impact decision-making of caregivers and policy makers . Jeopardize the conduct of future confirmatory trials 7 Recommended approach We advocate for the use of a “master protocol” to preserve data confidentiality and trial integrity until the scientific aims have been reliably addressed Master protocol = conventional clinical trial designed to extend across multiple sites and outbreaks Trial results are released only following the advice of an independent data monitoring committee (e.g. stop for efficacy, futility, reached target # of endpoints) and not due to lack of recruitment 8 Practical considerations Multi-site trial in high-risk areas with opportunity to add sites -
YALE Environmental NEWS
yale environmental n e w s The Yale Peabody Museum of Natural History, the School of Forestry & Environmental Studies, and the Yale Institute for Biospheric Studies spring 2008 · vol. 13, no. 2 Greetings from New YIBS Director Jeffrey Park see page 2 News from the Director of YIBS By Jeffrey Park RoseRita Riccitelli I was honored last autumn to be asked to serve as the Director of Yale’s faculty positions in Ecology & Evolutionary search for extraterrestrial life. An interdepart- at present, and a substantial public outreach Institute for Biospheric Studies by President Richard Levin and Provost Biology, and each year awards Gaylord mental hiring initiative in the broad field of effort has been proposed for the center. The Donnelley environmental postdoctoral fellow- microbiology has been presented to the Dean final form of the proposed institute is subject Andrew Hamilton. ships to researchers in the biodiversity of both of Yale College and the Provost. Establishing a to many uncertainties. At this stage of plan- our present world and in the geologic past. multi-departmental faculty cluster in the newly ning, however, one thing is clear: YIBS will play I have had the great benefit of succeeding That was 2004. This is 2008 and the stakes we YIBS seeded a faculty position in Geology acquired laboratories of Yale’s West Campus is an important role if the Yale Climate Institute Derek Briggs, whose able leadership of YIBS face are larger. The twin pressures on global & Geophysics, maintaining Yale’s leading one possible outcome of this effort. becomes a reality. has given me momentum and guidance for agriculture exerted by the developing world’s scholarship in how climate and atmospheric Biospheric studies at Yale serves broadly The Winter/Spring 2008 semester has the future. -
Framework for Equitable Allocation of COVID-19 Vaccine (2020)
THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. -
Turtles Without Borders Sea Turtles Are Rebounding, but Much Work Remains Fall 2019, Vol
FALL 2019 Turtles Without Borders Sea Turtles Are Rebounding, But Much Work Remains Fall 2019, Vol. 24, No. 3 Extracts Research briefs 5 Turtles Without Borders Sea turtles are rebounding, but much work remains 14 Center of Excellence UF grows $10 million grant into $1.7 billion gene therapy 24 company Brammer Bio RandallRuiz; cover photo, DavidTroeger Dr. Kent Fuchs President Dr. David Norton Vice President for Research Board of Trustees Mori Hosseini, Chair David L. Brandon James W. Heavener Leonard H. Johnson Thomas G. Kuntz Michael C. Murphy Daniel T. O’Keefe Rahul Patel Marsha D. Powers Jason J. Rosenberg Robert G. Stern Ray G. Thomas Anita G. Zucker Explore is published by UF Research. Opinions expressed do not reflect the official views of the university. Use of trade names implies no endorsement by the University of Florida. © 2019 University of Florida. The Writing Life explore.research.ufl.edu The University of Florida’s Editor: creative writing program Joseph M. Kays nurtures and pushes its [email protected] graduate students 30 Art Director: Katherine Kinsley-Momberger Design and Illustration: Katherine Kinsley-Momberger Ivan J. Ramos Mr. IPO Writers: Jay Ritter has spent his career Joseph Kays Cindy Spence tracking the emergence of new public companies Photography: John Jernigan 38 Charlotte Kesl Web Editor: Jewel Midelis Copy Editor: Bruce Mastron The Conversation Printing: Changing Tech's Face StorterChilds Printing, Gainesville Member of the University Research Magazine Association 42 www.urma.org Building a Better World Being forward-focused on a worthy goal is an essential attribute of any individual or organization that seeks relevance and impact in a complex endeavor. -
Technologies of Pandemic Control: Privacy and Ethics for COVID-19 Surveillance // 2
TECHNOLOGIES OF PANDEMIC CONTROL // Privacy and Ethics for COVID-19 Surveillance S.E. Freeman October 2020 Technologies of Pandemic Control // Privacy and Ethics for COVID-19 Surveillance S.E. Freeman October 2020 Contents Executive Summary 1 01 // INTRODUCTION 3 02 // TECHNOLOGICAL INTERVENTIONS 7 EXPOSURE NOTIFICATION AND DIGITAL PROXIMITY TRACING 8 How does it work? 9 Why use these interventions? 12 What concerns are raised? 13 Questionable effectiveness 13 Data could be re-identified 17 Could exacerbate existing inequalities 19 What requirements are needed to protect user privacy? 22 AGGREGATED LOCATION DATA 25 How does it work? 25 Why use this intervention? 26 What concerns are raised? 27 What requirements are needed to protect user privacy? 29 SYMPTOM-TRACKING APPLICATIONS 30 How does it work? 31 Why use this intervention? 32 What concerns are raised? 33 What requirements are needed to protect user privacy? 33 IMMUNITY PASSPORTS 34 How does it work? 34 Why use this intervention? 35 What concerns are raised? 35 What requirements are needed to protect user privacy? 38 03 // EXISTING REGULATORY FRAMEWORKS 40 APPLICABLE U.S. DATA PRIVACY REGULATIONS: A SNAPSHOT 41 FEDERAL LEGISLATION INTRODUCED FOR COVID-19 DATA 44 04 // CONCLUSIONS 47 05 // RECOMMENDATIONS 51 ACKNOWLEDGMENTS 56 ADDITIONAL RESOURCES 57 ABOUT THE CITRIS POLICY LAB & THE HUMAN RIGHTS CENTER 60 Executive Summary In response to the rapid spread of COVID-19 and its devastating effect on communities across the United States, private companies, state and local governments, nonprofits, and epidemiologists have been harnessing the powers of big data and technology in an attempt to better understand and contain the spread of the virus. -
What the Lightning-Fast Quest for Covid Vaccines Means
Feature MICHAEL CLEVENGER/GETTY The first US shipments of the joint Pfizer–BioNTech COVID-19 vaccine were ready by mid-December. making vaccines, such as by using messenger RNA (mRNA), have been validated by the WHAT THE LIGHTNING-FAST COVID-19 response, he adds. “It has shown that the development process can be accelerated QUEST FOR COVID VACCINES substantially without compromising on safety.” The world was able to develop COVID-19 MEANS FOR OTHER DISEASES vaccines so quickly because of years of pre- vious research on related viruses and faster The speedy approach used to tackle SARS-CoV-2 could ways to manufacture vaccines, enormous funding that allowed firms to run multiple change the future of vaccine science. By Philip Ball trials in parallel, and regulators moving more quickly than normal. Some of those factors might translate to other vaccine efforts, par- ticularly speedier manufacturing platforms. But there’s no guarantee. To repeat such hen scientists began seeking That speed of advance “challenges our rapid success will require similar massive fund- a vaccine for the SARS-CoV-2 whole paradigm of what is possible in vaccine ing for development, which is likely to come coronavirus in early 2020, they development”, says Natalie Dean, a biostatisti- only if there is a comparable sense of social were careful not to promise cian at the University of Florida in Gainesville. and political urgency. It will depend, too, on quick success. The fastest It’s tempting to hope that other vaccines might the nature of the pathogen. With SARS-CoV-2, any vaccine had previously now be made on a comparable timescale. -
In This Newsletter... Events Research Learn Connect
WINTER | 2021 IN THIS NEWSLETTER... Page 6 Page 4 Page 5 CONNECT MEETUPS Page 8 RESEARCH LEARN Page 3 Page 7 EVENTS Page 7 Page 2 Page 3 NISS Newsletter | SPRING 2017 | @NISS_DataSci | fb.com/NISSDataScience www.NISS.org | 1 DIRECTORS’ NOTES Welcome to the Winter 2021 NISS Parameters Newsletter! What a year it has been… one year ago in this Newsletter I made a prediction that the COVID-19 risk was low “if the epidemic can be contained” with then only 70K cases in the world. Well, it wasn’t contained in the US and now the world has ABOUT NISS seen more than 109M cases, and the US more than 27M. The number of coronavi- rus cases in the US has outstripped the common flu and with a recent fatality rate The National Institute of about 30 times higher. Statistical Sciences (NISS) is a national institute NISS responded to this year – a year like no other – by increasing the number of that delivers high-impact our outreach activities, both for our affiliates and for the general statistical science public. e W have partnered research in science and in with COPSS and now host COVID-19 Data Science Webinars twice a month, and we continue to host tutorials, public policy by leveraging workshops and virtual meetups every week. See below and signup for our email announcements. If you the rich expertise of its staff with that of its base would like to donate to support these activities, please go to the Donate button on our website home page. of affiliated organizations in academia, industry, An especially exciting upcoming event is the First CANSSI-NISS Health Data Science Workshop scheduled for and government. -
Natalie Exner Dean Curriculum Vitae
Natalie Exner Dean Curriculum Vitae CONTACT INFORMATION Department of Biostatistics Phone: (352) 294-1945 University of Florida Fax: (352) 294-1930 Dauer Hall 464 Email: nataliedean@ufl.edu P.O. Box 117450 Website: nataliexdean.com Gainesville, FL 32611 USA Twitter: @nataliexdean EDUCATION Ph.D. Biostatistics, Harvard University 2014 “Surveillance methods for monitoring HIV incidence & drug resistance” A.M. Biostatistics, Harvard University 2011 B.A. Mathematics/Statistics, Biology, Boston University, summa cum laude 2009 PROFESSIONAL EXPERIENCE Assistant Professor, Department of Biostatistics, University of Florida 2017–Present Postdoctoral Associate, Department of Biostatistics, University of Florida 2015–2017 External Statistical Consultant, HIV Department, World Health Organization 2014–2015 RESEARCH INTERESTS Public health surveillance, Infectious disease epidemiology, Emerging pathogens, Vaccine evaluation, Clinical trial design, Test negative designs PUBLICATIONS Refereed Journal Articles 1. Galler JR, Bryce CP, Waber D, Hock RS, Exner N, Eaglesfield D, Fitzmaurice G, Harrison R (2010). Early childhood malnutrition predicts depressive symptoms at ages 11-17. Jour- nal of Child Psychology and Psychiatry 51(7): 789-798. 2. Galler JR, Bryce CP, Zichlin ML, Waber DP, Exner N, Fitzmaurice GM, Costa PT (2013). Malnutrition in the first year of life and personality at age 40. Journal of Child Psychology and Psychiatry 54(8): 911-919. N. Dean, 1 of 15 3. Russo GS, Ferrucci AM, Miller CP, Dean EW, Strohbehn GW, Dean NE, Sharkey MS (2015). Factors associated with the transfer of pediatric patients with supracondylar humerus fractures to a level I pediatric trauma center. Connecticut Medicine 79(8): 461-466. 4. Ebola c¸a suffit ring vaccination trial consortium (coauthor Dean NE) (2015). -
COVID 19 Review
COVID 19 Review Monografia n. 5 Covid19 e i vaccini: a che punto siamo. A cura di Giorgio Banchieri, Antonio Giulio De Belvis, Maurizio Dal Maso, Stefania Mariantoni, Mario Ronchetti, Andrea Vannucci. Review realizzata in collaborazione con : 1 Nota redazionale. I materiali (articoli e dati) vengono selezionati da fonti accreditate: . Per gli articoli: The Lancet, British Medicine Journal, The New York Times, Science, Nature, Oxford Review, Cambridge Review, Quotidiano Sanità, Il Corriere della Sera, Il Sole 24Ore Sanità, La Repubblica e altri; Per le Istituzioni: . WH0/OMS, UE Centri di Prevenzione; OCDE, ONU, Protezione Civile, ISTAT, INAIL, Ministero Salute, ISS, AGENAS, CNR, Regioni, ARS, ASL, AO, AOP, IRCCS, Centri Studi e ricerche nazionali e internazionali e altri; Per i dati: . WH0/OMS, UE Centri di Prevenzione; OCDE, ONU, Protezione Civile, ISTAT, INAIL, Ministero Salute, ISS, AGENAS, CNR, Regioni, ARS, ASL, AO, AOP, IRCCS, Centri Studi e ricerche nazionali e internazionali e altri; Criteri di selezione: I materiali sono scelti in base ai seguenti criteri: Materiali di analisi recenti; Fonti accreditate; Tematiche inerenti a COVID19; Procedure internazionali e nazionali; Studi e ricerche epidemiologici; Studi su procedure per operatori sanitari e sociali; Linee Guida internazionali, nazionali e regionali; Linee Guida di società scientifiche e professionali. Le traduzioni sono fatte in automatico con il software “google” per rapidità di fruizione. Ci scusiamo se le traduzioni non sono sempre adeguate, ma riteniamo più utile la